Overview
Headquarters
Greater Boston Area, East Coast, New England
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager’s wholly-owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson’s disease, Huntington’s disease, a monogenic form of ALS called SOD1, Friedreich’s ataxia, Alzheimer’s disease, and other neurodegenerative diseases related to defective or excess aggregation of tau and alpha-synuclein proteins in the brain. Voyager has strategic collaborations with AbbVie and Neurocrine Biosciences. Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager is headquartered in Cambridge, Massachusetts. Contact: Voyager Therapeutics 75 Sidney St. Cambridge, MA 02139 [email protected] 857-259-5340 Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company. The Company focuses on developing life-changing treatments for patients suffering from severe diseases of the central nervous system. Voyager Therapeutics develops gene therapies for fatal and debilitating diseases. Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system ,Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system Voyager Therapeutics, Inc. is located in Cambridge, MA, United States and is part of the Biotechnology Product Manufacturing Industry. Voyager Therapeutics, Inc. has 88 total employees across all of its locations and generates $171.13 million in sales (USD). There are 2 companies in the Voyager Therapeutics, Inc. corporate family. Voyager Therapeutics, Inc. is located in Cambridge, MA, United States and is part of the Biotechnology Product Manufacturing Industry. Voyager Therapeutics, Inc. has 88 total employees across all of its locations and generates $171.13 million in sales (USD). There are 2 companies in the Voyager Therapeutics, Inc. corporate family.
